These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 29410489)
1. Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration. Muller M; Guillaud-Bataille M; Salleron J; Genestie C; Deveaux S; Slama A; de Paillerets BB; Richard S; Benusiglio PR; Ferlicot S Mod Pathol; 2018 Jun; 31(6):974-983. PubMed ID: 29410489 [TBL] [Abstract][Full Text] [Related]
2. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Chen YB; Brannon AR; Toubaji A; Dudas ME; Won HH; Al-Ahmadie HA; Fine SW; Gopalan A; Frizzell N; Voss MH; Russo P; Berger MF; Tickoo SK; Reuter VE Am J Surg Pathol; 2014 May; 38(5):627-37. PubMed ID: 24441663 [TBL] [Abstract][Full Text] [Related]
3. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816 [TBL] [Abstract][Full Text] [Related]
4. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274 [TBL] [Abstract][Full Text] [Related]
5. Morphology and Immunohistochemistry for 2SC and FH Aid in Detection of Fumarate Hydratase Gene Aberrations in Uterine Leiomyomas From Young Patients. Joseph NM; Solomon DA; Frizzell N; Rabban JT; Zaloudek C; Garg K Am J Surg Pathol; 2015 Nov; 39(11):1529-39. PubMed ID: 26457356 [TBL] [Abstract][Full Text] [Related]
6. Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases. Bennett JA; Weigelt B; Chiang S; Selenica P; Chen YB; Bialik A; Bi R; Schultheis AM; Lim RS; Ng CKY; Morales-Oyarvide V; Young RH; Reuter VE; Soslow RA; Oliva E Mod Pathol; 2017 Oct; 30(10):1476-1488. PubMed ID: 28664937 [TBL] [Abstract][Full Text] [Related]
7. Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. Smith SC; Trpkov K; Chen YB; Mehra R; Sirohi D; Ohe C; Cani AK; Hovelson DH; Omata K; McHugh JB; Jochum W; Colecchia M; Amin M; Divatia MK; Hes O; Menon S; Werneck da Cunha I; Tripodi S; Brimo F; Gill AJ; Osunkoya AO; Magi-Galluzzi C; Sibony M; Williamson SR; Nesi G; Picken MM; Maclean F; Agaimy A; Cheng L; Epstein JI; Reuter VE; Tickoo SK; Tomlins SA; Amin MB Am J Surg Pathol; 2016 Nov; 40(11):1457-1472. PubMed ID: 27635946 [TBL] [Abstract][Full Text] [Related]
8. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Gupta S; Swanson AA; Chen YB; Lopez T; Milosevic D; Kipp BR; Leibovich BC; Thompson RH; Herrera-Hernandez L; Cheville JC; Jimenez RE Hum Pathol; 2019 Sep; 91():114-122. PubMed ID: 31299266 [TBL] [Abstract][Full Text] [Related]
9. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276 [TBL] [Abstract][Full Text] [Related]
10. Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry. Reyes C; Karamurzin Y; Frizzell N; Garg K; Nonaka D; Chen YB; Soslow RA Mod Pathol; 2014 Jul; 27(7):1020-7. PubMed ID: 24309325 [TBL] [Abstract][Full Text] [Related]
11. The Role of Morphology in Predicting Fumarate Hydratase-deficient Uterine Leiomyomas in Young Women. Bayram A; Bagbudar S; Sozen H; Onder S; Yavuz E Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):657-660. PubMed ID: 37751278 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in Cutaneous Leiomyomas May Aid in Identification of Patients With HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome). Buelow B; Cohen J; Nagymanyoki Z; Frizzell N; Joseph NM; McCalmont T; Garg K Am J Surg Pathol; 2016 Jul; 40(7):982-8. PubMed ID: 26945337 [TBL] [Abstract][Full Text] [Related]
13. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression. Anderson WJ; Tsai HK; Sholl LM; Hirsch MS Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731 [No Abstract] [Full Text] [Related]
15. Fumarate Hydratase-Deficient Leiomyoma of the Uterine Corpus: Comparative Morphologic Analysis of Protein-Deficient Tumors With and Without Pathogenic Germline Fumarate Hydratase Gene Mutations. Shi W; Liu Y; Aisagbonhi O; Roma AA; Hasteh F; Zare SY; Fadare O Int J Surg Pathol; 2024 Apr; 32(2):340-355. PubMed ID: 37312573 [TBL] [Abstract][Full Text] [Related]
16. Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma. Mannan R; Wang X; Bawa PS; Chugh S; Chinnaiyan AK; Rangaswamy R; Zhang Y; Cao X; Smith SC; Trpkov K; Williamson SR; Sangoi AR; Mohanty S; McKenney JK; Gupta S; Magi-Galluzzi C; Argani P; Osunkoya AO; Chinnaiyan AM; Dhanasekaran SM; Mehra R Hum Pathol; 2023 Apr; 134():102-113. PubMed ID: 36581128 [TBL] [Abstract][Full Text] [Related]
17. [Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases]. Wang XX; Liu Y; Liu LC; Wang YX; Yang J; Hu AJ; Zhang B; Liu CR Zhonghua Bing Li Xue Za Zhi; 2023 Jun; 52(6):574-579. PubMed ID: 37263921 [No Abstract] [Full Text] [Related]
18. Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms. Kuroda N; Tsutsui M; Iguchi M; Nobuoka E; Uehara T; Sonobe Y; Morinaga Y; Shibuya S; Oda W; Yanai H; Kawada C; Karashima T; Yamasaki I; Inoue K; Nagashima Y Ann Diagn Pathol; 2020 Dec; 49():151599. PubMed ID: 32977234 [TBL] [Abstract][Full Text] [Related]
19. Low-Grade Fumarate Hydratase-Deficient Renal Cell Carcinoma in a 30-Year-Old Female. Wyvekens N; Anderson WJ; Kim YX; Carter M; Hirsch MS Int J Surg Pathol; 2022 Apr; 30(2):184-189. PubMed ID: 34180725 [TBL] [Abstract][Full Text] [Related]
20. Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses. El-Zaatari Z; Divatia MK Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S7-S17. PubMed ID: 32108620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]